Endo International hastily files creditor sale agreement

Chicago, July 7 – Endo International plc filed a sale agreement, due by July 7, but made a special point of saying that the terms are subject to negotiation and may change, according to filings with the U.S. Bankruptcy Court for the Southern District of New York just before the deadline.

The sale hearing, as previously reported, was moved to Aug. 4 from July 28.

The company is selling its assets to the stalking horse bidder, an entity formed by prepetition first-lien debtholders.

As previously noted, the stalking horse agreement includes a credit bid of $5.9 billion of prepetition first-lien debt.

Endo is a Dublin, Ireland-based specialty pharmaceutical company that filed bankruptcy on Aug. 16, 2022. The Chapter 11 case number is 22-22549.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.